The pharma industry faces an urgent need for standardization and intelligent automation in pharmacovigilance (PV) and safety monitoring. The pre-existing process challenges are compounded by adverse event (AE) case volume overload and reporting inefficiencies. This demand is leading to a sharp iOriginal Article
You may also like
New alloys for manufacturing freeze-dryers
Navigating the Complexities of Emerging Therapy...
INTERPHEX 2025: Preventing Spills in the Manufacturing...
Agentic AI Growth Predicted, but More Than Half of...
Microsoft and SkyCell Collaborate on Pharma Supply...
Siemens Acquires Dotmatics, Extending AI Software...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.